William Blair & Company’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $875K | Sell |
|
|||||
|
2025
Q1 | $971K | Sell |
|
|||||
|
2024
Q4 | $991K | Buy |
|
|||||
|
2024
Q3 | $922K | Buy |
|
|||||
|
2024
Q2 | $770K | Sell |
|
|||||
|
2024
Q1 | $669K | Sell |
|
|||||
|
2023
Q4 | $654K | Sell |
|
|||||
|
2023
Q3 | $607K | Hold |
|
|||||
|
2023
Q2 | $730K | Sell |
|
|||||
|
2023
Q1 | $752K | Sell |
|
|||||
|
2022
Q4 | $683K | Sell |
|
|||||
|
2022
Q3 | $881K | Sell |
|
|||||
|
2022
Q2 | $915K | Sell |
|
|||||
|
2022
Q1 | $1.38M | Sell |
|
|||||
|
2021
Q4 | $2.32M | Buy |
|
|||||
|
2021
Q3 | $2.08M | Buy |
|
|||||
|
2021
Q2 | $1.92M | Sell |
|
|||||
|
2021
Q1 | $4.41M | Sell |
|
|||||
|
2020
Q4 | $3.22M | Buy |
|
|||||
|
2020
Q3 | $2.32M | Buy |
|
|||||
|
2020
Q2 | $2.4M | Sell |
|
|||||
|
2020
Q1 | $1.64M | Sell |
|
|||||
|
2019
Q4 | $3.01M | Buy |
|
|||||
|
2019
Q3 | $2.84M | Sell |
|
|||||
|
2019
Q2 | $9.12M | Sell |
|
|||||
|
2019
Q1 | $11.4M | Sell |
|
|||||
|
2018
Q4 | $19.8M | Buy |
|
|||||
|
2018
Q3 | $37M | Sell |
|
|||||
|
2018
Q2 | $28.6M | Buy |
|
|||||
|
2018
Q1 | $21.8M | Buy |
|
|||||
|
2017
Q4 | $16.8M | Sell |
|
|||||
|
2017
Q3 | $16.9M | Sell |
|
|||||
|
2017
Q2 | $15.7M | Buy |
|
|||||
|
2017
Q1 | $13.5M | Buy |
|
|||||
|
2016
Q4 | $11.7M | Buy |
|
|||||
|
2016
Q3 | $8.72M | Buy |
|
|||||
|
2016
Q2 | $8.11M | Buy |
|
|||||
|
2016
Q1 | $6.92M | Buy |
|
|||||
|
2015
Q4 | $6.67M | Sell |
|
|||||
|
2015
Q3 | $11.6M | Sell |
|
|||||
|
2015
Q2 | $148M | Buy |
|
|||||
|
2015
Q1 | $113M | Buy |
|
|||||
|
2014
Q4 | $62M | Buy |
|
|||||
|
2014
Q3 | $49.6M | Buy |
|
|||||
|
2014
Q2 | $52.6M | Sell |
|
|||||
|
2014
Q1 | $63M | Sell |
|
|||||
|
2013
Q4 | $62.9M | Buy |
|
|||||
|
2013
Q3 | $9.35M | Buy |
|